Oulu-based Finnadvance is one of the 13 companies that received funding for a doctoral-business collaboration project in the Post Docs in Companies program (PoDoCo®).
PoDoCo grants have been awarded to all disciplines. Engineering and natural sciences have been the most represented, but companies have also sought out experts in the social sciences and humanities to reform their operations. Grants worth around one million will be distributed throughout the PoDoCo program in 2022.
Finnadvance focuses on organs on chips and microfluidic cell culture devices for drug research and development. The company has developed a platform that allows for parallel cultures for molecule screening and pre-clinical studies.
PoDoCo program is funded by Finnish Cultural Foundation, Jenny and Antti Wihuri Foundation, Maa- ja vesitekniikan tuki ry, Svenska Kulturfonden, The Society of Swedish Literature in Finland (SLS), Finnish Foundation for Technology Promotion, Maj and Tor Nessling Foundation, Foundation for Economic Education, KAUTE Foundation and The Paulo Foundation. The total funding is up to million euros every year, which enables around 35 PoDoCo grants each year.